Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $80 thousand versus the consensus estimate of $431.38 thousand.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.